SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-21-010775
Filing Date
2021-11-15
Accepted
2021-11-12 21:48:56
Documents
7
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 8114
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 532378
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 610163
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 6102
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 6211
6 GRAPHIC exhibit99-3x001.jpg GRAPHIC 3487
7 GRAPHIC exhibit99-4x001.jpg GRAPHIC 3772
  Complete submission text file 0001062993-21-010775.txt   1174333
Mailing Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4
Business Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4 (416) 854-8884
FSD Pharma Inc. (Filer) CIK: 0001771885 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39152 | Film No.: 211405882
SIC: 2834 Pharmaceutical Preparations